Skip to content

Non-anesthesiologist administrated propofol (NAAP) during endoscopic mucosal resection (EMR) of colorectal polyps

Non-anesthesiologist administrated propofol (NAAP) during endoscopic mucosal resection (EMR) of colorectal polyps - EMR under NAAP

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000013447
Enrollment
100
Registered
2014-03-18
Start date
2014-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal polyps

Interventions

None listed

Sponsors

Naoyuki Tominaga
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patients who are going to treat colorectal polyps in our or clinical cooperated hospital. 2) The patients who can understand the study and approve the treatment.

Exclusion criteria

Exclusion criteria: 1) Performance Status (PS) 3 or 4. 2) American Society of Anesthesiologists (ASA) class over 3. 3) The patients who cannot stop their anticoagulation therapy. 4) The patients who cannot take the therapy because of their complications. 5) The patients who want to take the therapy, or the patients who were inappropriate condition. 6) The patients who were impossible to take the therapy at the discretion of primary doctor.

Design outcomes

Primary

MeasureTime frame
We evaluate the safety by hemodynamics monitoring, the patients satisfaction and VAS(Visual Analog Scale) using questionnaires.

Countries

Japan

Contacts

Public ContactNaoyuki Tominaga

Tokyo medical university Department of Gastroenterology and Hepatology

aerasnt@gmail.com03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026